- This event has passed.
BioNJ’s COVID-19 Rapid Fire Research Showcase
June 5 @ 9:00 am - 10:00 am
BioNJ COVID-19 Rapid Fire Research Showcase
Known as the Medicine Chest of the World, New Jersey is leading the way on COVID-19 research. Join us on Friday, June 5, for a BioNJ COVID-19 Rapid Fire Research Showcase featuring innovative companies leading the way in groundbreaking COVID-19 research. From vaccines, cell and gene therapy, treatments and therapeutics, our presenters will highlight the important science coming from New Jersey and beyond!
Whether you are an investor, banker or innovator seeking partners or an otherwise interested party, plan to join us on June 5 and June 16. Registration is $55 for BioNJ Members and $95 for Future Members. Each session has a unique registration link. (see below)
|
Friday, June 5, 2020, 9:00 a.m. – 10:00 a.m.
|
You’ll hear from and have the opportunity to ask questions of these companies:
Allied Innovation Systems, BioAegis Therapeutics, Caladrius, Chromocell, Evrys Bio, MAVEN Diagnostic Inc. (an IMS Company), OncoSec Medical, PharmaJet, RTM Vital Signs and Soligenix
Plus, kicking off the program, Phyllis Arthur, Vice President of Infectious Diseases & Diagnostics Policy at BIO, will provide an overview of the industry’s response to this unfathomable pandemic — including more than 500 research programs globally.
|
Tuesday, June 16, 2020, 10:00 a.m. – 11:00 a.m.
|
You’ll hear from and have the opportunity to ask questions of these companies:
Ayma Therapeutics, Balanced Biotech, BalinBac Therapeutics, Embio Diagnostics, Genovation BioScience, Globex Health, Humanigen, Innoplexus, Insmed, MedifVu, Orthobond PReP Biopharm, Sen-Jam Pharmaceutical and Synechion
Plus, enjoy a Keynote by Dr. Robert Hariri, Founder and CEO of Celularity, a clinical-stage cell therapeutics company working on two cell and gene therapies for COVID-19.
Thank You To Our Sponsors
